APA (7th ed.) Citation

AD, A., SE, P., SA, P., NM, A., & P, M. (2019). Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 34(12), 2220. https://doi.org/10.1002/jbmr.3853

Chicago Style (17th ed.) Citation

AD, Anastasilakis, Papapoulos SE, Polyzos SA, Appelman-Dijkstra NM, and Makras P. "Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial." Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 34, no. 12 (2019): 2220. https://doi.org/10.1002/jbmr.3853.

MLA (9th ed.) Citation

AD, Anastasilakis, et al. "Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial." Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, vol. 34, no. 12, 2019, p. 2220, https://doi.org/10.1002/jbmr.3853.